Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles.

Autor: Kosgodage US; Cellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London, United Kingdom., Matewele P; Cellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London, United Kingdom., Awamaria B; Cellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London, United Kingdom., Kraev I; School of Life, Health and Chemical Sciences, The Open University, Milton Keynes, United Kingdom., Warde P; Bioscience Research Group, Extracellular Vesicle Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom., Mastroianni G; School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom., Nunn AV; Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom., Guy GW; GW Pharmaceuticals Research, Cambridge, United Kingdom., Bell JD; Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom., Inal JM; Bioscience Research Group, Extracellular Vesicle Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom., Lange S; Tissue Architecture and Regeneration Research Group, School of Life Sciences, University of Westminster, London, United Kingdom.

Publikováno v: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2019 Sep 10; Vol. 9, pp. 324. Date of Electronic Publication: 2019 Sep 10 (Print Publication: 2019).

Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells.

Autor: Kosgodage US; Cellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London, UK. Electronic address: uchini22@hotmail.co.uk., Uysal-Onganer P; Cancer Research Group, School of Life Sciences, University of Westminster, London, UK. Electronic address: P.onganer@westminster.ac.uk., MacLatchy A; Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, UK. Electronic address: amy.maclatchy@my.westminster.ac.uk., Mould R; Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, UK. Electronic address: rhys.mould@my.westminster.ac.uk., Nunn AV; Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, UK. Electronic address: alistair.nunn@btconnect.com., Guy GW; GW Research, Sovereign House, Vision Park, Cambridge, CB24 9BZ, UK. Electronic address: gwg@chedingtoncourt.co.uk., Kraev I; The Open University, Walton Hall, Milton Keynes, UK. Electronic address: igor.kraev@open.ac.uk., Chatterton NP; The Open University, Walton Hall, Milton Keynes, UK. Electronic address: nicholas.chatterton@open.ac.uk., Thomas EL; Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, UK. Electronic address: l.thomas3@westminster.ac.uk., Inal JM; Extracellular Vesicle Research Unit and Biosciences Research Group, School of Life and Medical Sciences, University of Hertfordshire, College Lane, Hatfield, UK. Electronic address: j.inal@herts.ac.uk., Bell JD; Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, UK. Electronic address: J.Bell@westminster.ac.uk., Lange S; Tissue Architecture and Regeneration Research Group, School of Life Sciences, University of Westminster, London, UK. Electronic address: S.lange@westminster.ac.uk.

Publikováno v: Translational oncology [Transl Oncol] 2019 Mar; Vol. 12 (3), pp. 513-522. Date of Electronic Publication: 2018 Dec 28.

Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer.

Autor: Kosgodage US; Cellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London, United Kingdom., Mould R; Research Centre for Optimal Health, Department of Life Sciences, University of Westminster, London, United Kingdom., Henley AB; Research Centre for Optimal Health, Department of Life Sciences, University of Westminster, London, United Kingdom., Nunn AV; Research Centre for Optimal Health, Department of Life Sciences, University of Westminster, London, United Kingdom., Guy GW; GW Research, Sovereign House Vision Park, Cambridge, United Kingdom., Thomas EL; Research Centre for Optimal Health, Department of Life Sciences, University of Westminster, London, United Kingdom., Inal JM; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom., Bell JD; Research Centre for Optimal Health, Department of Life Sciences, University of Westminster, London, United Kingdom., Lange S; Tissue Architecture and Regeneration Research Group, Department of Biomedical Sciences, University of Westminster, London, United Kingdom.; Department of Pharmacology, University College London School of Pharmacy, London, United Kingdom.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2018 Aug 13; Vol. 9, pp. 889. Date of Electronic Publication: 2018 Aug 13 (Print Publication: 2018).

Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy.

Autor: Kosgodage US; Cellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, 166-220 Holloway Road, London N7 8DB, UK. uck0002@my.londonmet.ac.uk., Trindade RP; University College London School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, UK. ana.trindade.14@ucl.ac.uk., Thompson PR; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01655, USA. Paul.Thompson@umassmed.edu., Inal JM; Cellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, 166-220 Holloway Road, London N7 8DB, UK. j.inal@londonmet.ac.uk., Lange S; University College London School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, UK. S.Lange@westminster.ac.uk.; Department of Biomedical Sciences, University of Westminster, 115, New Cavendish Street, London W1W 6UW, UK. S.Lange@westminster.ac.uk.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2017 May 09; Vol. 18 (5). Date of Electronic Publication: 2017 May 09.